Skip to main content
Juan Lertora, MD, Internal Medicine, Baton Rouge, LA

Juan Jose Luis Lertora MD


Physician

Join to View Full Profile
  • 6400 Perkins RoadBaton Rouge, LA 70808

  • Phone+1 225-763-0945

Dr. Lertora is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1975 - 1977
  • Other
    OtherClass of 1970

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1977 - 2026
  • LA State Medical License
    LA State Medical License 1980 - 2025
  • CT State Medical License
    CT State Medical License 1977 - 2022
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Clinical Evaluation Of Flowable Composite ResinNational Center For Research Resources2006
  • Trial Of Two Potent, Simplified Regimens Utilizing A Protease Inhibitor-SparingNational Center For Research Resources2005
  • Quality Assessment Study For Viable Peripheral Blood Mononuclear Cells (PBMC)National Center For Research Resources2005
  • Trial Of Two Potent, Simplified RegimensNational Center For Research Resources2004
  • Study Of Prolongation Of Virologic Success And Options From Failure In HIVNational Center For Research Resources2004
  • Quality Assessment Study For PbmcsNational Center For Research Resources2004
  • Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–2002
  • Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–2002
  • AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1996–2002
  • Salvage Antiretroviral TherapiesNational Center For Research Resources2000–2001
  • Protein Supplements In HIV+ Subjects With Weight LossNational Center For Research Resources2000–2001
  • Protease Inhibitors And Lipid Lowering AgentsNational Center For Research Resources2000–2001
  • Protease Inhibitor/Non-Nucleoside RT InhibitorNational Center For Research Resources2000–2001
  • Phase II Study Of Hydroxyurea In HIV InfectionNational Center For Research Resources2000–2001
  • Oncogenic Viral Pathogenesis/Cancer Risk Factors In AIDSNational Center For Research Resources2000–2001
  • Interleukin 2 PLUS Highly Active Antiretroviral TherapyNational Center For Research Resources2000–2001
  • ACTG 398:Amprenavir As PART Of Dual Protease Inhibitor Regimens In HINational Center For Research Resources1999–2001
  • ACTG 388:Trial Of Efavirenz Or Nelfinavir In Combination W/ 3tc/Zdv &National Center For Research Resources1999–2001
  • ACTG 372:Study Of Prolongation Of Virologic Success &Options From FANational Center For Research Resources1999–2001
  • ACTG 368--Trial Of 1592U89 In Combination W/ IDV And Dmp-266 In HIV+National Center For Research Resources1998–2001
  • ACTG 343--Trial Of 3 Maintenance Regimens For HIV+ SubjectsNational Center For Research Resources1998–2001
  • ACTG 328--Intermittent Recombinant Human IL2 + Haart VS Haart Alone--AidsNational Center For Research Resources1998–2001
  • ACTG 383:Dynamics Of Hepatitis C In Patients Infected W/ Hepatitis CNational Center For Research Resources1999–2000
  • ACTG 309:Pharmacokinetics Of Antituberculosis Agents In HIV InfectedNational Center For Research Resources1999–2000
  • ACTG 359--Activity Of Soft Gelatin Capsule Saquinavir In Combination--Hiv+National Center For Research Resources1998–2000
  • ACTG 313--Megestrol Acetate/Testosterone Enanthate Combination VS Alone In AIDSNational Center For Research Resources1998–2000
  • ACTG 320--Phase III Study Of Indinavir With ZDV And 3TC In Subjects With HIVNational Center For Research Resources1997–2000
  • ACTG 248--Phase II Study Of IL 2 By Subcutaneous Injection Of Hiv/AntiretroviralNational Center For Research Resources1997–2000
  • ACTG 336--Study Of Nitazoxanide (NTZ) For AIDS CryptosporidiosisNational Center For Research Resources1998–1999
  • Acetylation Activity In HIV Positive Individuals And The Potential Drug ReactionNational Center For Research Resources1998–1999
  • ACTG 333--Hard Capsule Saquinavir VS Soft Gelatin Saquinavir VS IndinavirNational Center For Research Resources1997–1999
  • Menstrual Cycle And Drug Metabolism--P450 IsozymesNational Center For Research Resources1997
  • Acetylation Activity In HIV Positive Individuals And Potential Drug ReactionNational Center For Research Resources1997
  • Correlation Of Ethylene Dichloride Oxidate Metabolism And ChlorzoxazoneNational Center For Research Resources1996–1997

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: